论文信息 - Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience - 字舞流文

Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience

C. Leo | E. Biskup | M. Vetter | C. Taverna | A. Müller | D. Thorn | D. Koychev | C. U. Nussbaum | Elena Laura Georgescu Margarint | Céline Montavon Sartorius | Alexander Schreiber